Collected works of David AG Galton

Dr. David A. G. Galton (1922-2006) was a skilled morphologist who produced major contributions to hematology in his diagnosis and classification of cancers of the blood, including prolymphocytic leukemia, and in his clinical trials of busulphan, chlorambucil and melphalan, which became the standard treatments for chronic myeloid leukemia, chronic lymphocytic leukemia, and multiple myeloma, respectively, for a period of four decades. His 1963 thesis on the natural history of CLL is the source of the WBC patterns seen in CLL (Types I, IIa and IIb); this concept was later rediscovered as the lymphocyte doubling time (LDT). Dr. Galton was well known for his leadership and participation in the Medical Research Council (MRC) and its Leukaemia Research Unit at the Royal Postgraduate Medical School (RPMS) at Hammersmith Hospital, and he was a founding member of the French-American-British (FAB) group. In 1986, he was awarded the rank of Commander of the Order of the British Empire (CBE). He was posthumously awarded the Rai-Binet Medal in 2007 for his work on the natural history of CLL and introduction of chlorambucil for the treatment of CLL.

Image from Hoffbrand AV. Haematology at the Hammersmith Hospital and Royal Postgraduate Medical School 1934-1994. Br J Haematol. 2003;123(2):207-218.

A collection of his letters may be found in this archive.

Collected Works

1948

• Galton DAG. British Empire Cancer Campaign. Nature. 1948 Oct 23;162(4121):664. 

1949

• Galton DAG, Hieger I, Lamerton LF. Progress of cancer research. Nature. 1949 Sep 24;164(4169):523-5. 

1950

• Galton DAG. Androgen therapy in 70 cases of advanced mammary carcinoma. Br J Cancer. 1950 Mar;4(1):20-58. 

1951

• Galton DAG. IV. Aromatic nitrogen mustards in the reticuloses. Br J Radiol. 1951 Sep;24(285):511-3. 

1952

• Christie AC, Galton DAG. A fatal case of intestinal lipodystrophy of Whipple investigated during life. J Pathol Bacteriol. 1952 Apr;64(2):351-66. 

1953

• Galton DAG. Myleran in chronic myeloid leukaemia: results of treatment. Lancet. 1953 Jan 31;264(6753):208-13. 
• Galton DAG. I. Some observations on chronic myeloid leukaemia. Br J Radiol. 1953 Jun;26(306):285-90. 

1955

• Galton DAG, Till M. Myleran in chronic myeloid leukaemia. Lancet. 1955 Feb 26;268(6861):425-30. 
• Galton DAG, Israels LG, Nabarro JDN, Till M. Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma. Br Med J. 1955 Nov 12;2(4949):1172-6. 

1956

• Galton DAG. The management of leukaemia. Med World. 1956 Jan;84(1):9-14.
• Galton DAG. The use of myleran and similar agents in chronic leukemias. Adv Cancer Res. 1956;4:73-112. 

1958

• Galton DAG. Busulphan therapy. Br Med J. 1958 Jan 25;1(5064):216. 
• Israels LG, Galton DAG, Till M, Wiltshaw E. Clinical evaluation of CB 1348 in malignant lymphoma and related diseases. Ann N Y Acad Sci. 1958 Apr 24;68(3):915-25. 
• Galton DAG, Till M, Wiltshaw E. Busulfan (1, 4-dimethanesulfonyloxybutane, myleran); summary of clinical results. Ann N Y Acad Sci. 1958 Apr 24;68(3):967-73. 
• Papac R, Galton DAG, Till M, Wiltshaw E. Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506). Ann N Y Acad Sci. 1958 Apr 24;68(3):1126-7. 
• Galton DAG. The present status of chemotherapy in leukaemia. Acta Haematol. 1958 Jul-Oct;20(1-4):40-3. 
• Elson LA, Galton DAG, Till M. The action of chlorambucil (CB. 1348) and busulphan (myleran) on the haemopoietic organs of the rat. Br J Haematol. 1958 Oct;4(4):355-74. 

1959

• Galton DAG. Treatment of the chronic leukaemias. Br Med Bull. 1959 Jan;15(1):78-85. 

1960

• Galton DAG. Malignant lymphoma and leukaemias. Cancer Prog. 1960:226-31.

1961

• Galton DAG, Wiltshaw E, Szur L, Dacie JV. The use of chlorambucil and steroids in the treatment of chronic lymphocytic leukaemia. Br J Haematol. 1961 Jan;7:73-98. 
• Galton DAG. Chemotherapy in malignant disease. Introduction. Postgrad Med J. 1961 Jun;37:338-41. 

1962

• Galton DAG. The management of leukaemia in pregnancy. Proc R Soc Med. 1962 Sep;55:760-2. 

1963

• Galton DAG. M.R.C. report on leukaemia. Br Med J. 1963 Jun 8;1(5344):1541. 

1964

• Speed DE, Galton DAG, Swan A. Melphalan in the treatment of myelomatosis. Br Med J. 1964 Jun 27;1(5399):1664-9. 

1965

• Galton DAG. Clinical trials in progress: leukaemia and multiple myeloma. Proc R Soc Med. 1965 Aug;58:630-2. 

1966

• Lawler SD, Galton DAG. Chromosome changes in the terminal stages of chronic granulocytic leukaemia. Acta Med Scand Suppl. 1966;445:312-8. 
• Galton DAG. The pathogenesis of chronic lymphocytic leukemia. Can Med Assoc J. 1966 May 7;94(19):1005-10. 
• Penny R, Galton DAG, Scott JT, Eisen V. Studies on neutrophil function. I. Physiological and pharmacological aspects. Br J Haematol. 1966 Sep;12(5):623-32. 
• Penny R, Galton DAG. Studies on neutrophil function. II. Pathological aspects. Br J Haematol. 1966 Sep;12(5):633-45. 
• Galton DAG. Some problems in the management of leukaemia and lymphoma. Proc R Soc Med. 1966 Dec;59(12):1268-72. 

1967

• Morley AA, Baikie AG, Galton DAG. Cyclic leucocytosis as evidence for retention of normal homoeostatic control in chronic granulocytic leukaemia. Lancet. 1967 Dec 23;2(7530):1320-3. 

1968

• Galton DAG, Peto R. A progress report on the Medical Research Council’s therapeutic trial in myelomatosis. Br J Haematol. 1968 Sep;15(3):319-20. 

1969

• Weatherall DJ, Galton DAG, Kay HE. Busulphan and bone marrow depression. Br Med J. 1969 Mar 8;1(5644):638. 
• Galton DAG. Principles of therapy in leukaemia. J R Coll Physicians Lond. 1969 Apr;3(3):230-237. 
• Galton DAG. The possibility of radical chemotherapy in chronic myelocytic leukaemia. Haematol Lat. 1969 Jul-Dec;12(3):703-9.
• Galton DAG. Chemotherapy of chronic myelocytic leukemia. Semin Hematol. 1969 Oct;6(4):323-43.
• Catovsky D, Holt PJ, Galton DAG. Lymphocyte cultures in multiple myeloma and other paraproteinaemias. Br J Haematol. 1969 Dec;17(6):608-9. 

1970

• Hamilton-Fairley G, Malpas JS, Galton DAG. Clinical experience with L-asparaginase. Recent Results Cancer Res. 1970;33:257-62. 
• Beard ME, Crowther D, Galton DAG, Guyer RJ, Fairley GH, Kay HE, Knapton PJ, Malpas JS, Scott RB. L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J. 1970 Jan 24;1(5690):191-5. 
• Catovsky D, Ikoku NB, Pitney WR, Galton DAG. Thromboembolic complications in myelomatosis. Br Med J. 1970 Aug 22;3(5720):438-9. 
• Spiers AS, Galton DAG. Improved semilogarithmic haematological chart. Br Med J. 1970 Aug 22;3(5720):458-9. 

1971

• Galton DAG, Spiers AS. Progress in the leukemias. Prog Hematol. 1971;7(0):343-405.
• Catovsky D, Galton DAG. Myelomonocytic leukaemia supervening on chronic lymphocytic leukaemia. Lancet. 1971 Mar 6;1(7697):478-9.
• Galton DAG. Treatment of myelomatosis–M.R.C. trial. Br Med J. 1971 May 8;2(5757):323-4. 
• Brandes LJ, Galton DAG, Wiltshaw E. New approach to immunotherapy of melanoma. Lancet. 1971 Aug 7;2(7719):293-5. 
• Catovsky D, Galton DAG, Griffin C. The significance of lysozyme estimations in acute myeloid and chronic monocytic leukaemia. Br J Haematol. 1971 Nov;21(5):565-80. 
• Catovsky D, Galton DAG, Griffin C, Hoffbrand AV, Szur L. Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders. Br J Haematol. 1971 Dec;21(6):661-72. 

1972

• Catovsky D, Galton DAG, Robinson J. Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia. Scand J Haematol. 1972;9(2):142-8. 
• Catovsky D, Galton DAG. Cytochemical demonstration of lysozyme and nitroblue tetrazolium reduction in leukaemia monocytes. Br J Haematol. 1972 May;22(5):634-5.
• Catovsky D, Holt PJ, Galton DAG. Binucleated blast-cells in lymphocyte cultures from myelomatosis. Immunology. 1972 Jun;22(6):1103-9. 
• Catovsky D, Holt PJ, Galton DAG. Lymphocyte transformation in immunoproliferative disorders. Br J Cancer. 1972 Jun;26(3):154-63. 
• Galton DAG, Spiers AS. The Hammersmith Hospital Anaemia Unit, and the Medical Research Council’s Leukaemia Unit at the Royal Postgraduate Medical School. Br J Haematol. 1972 Sep;23(Suppl):215-21. 
• Rubens RD, Wiltshaw E, Boesen E, Galton DAG. Multiple-drug therapy in Hodgkin’s disease. Eur J Cancer. 1972 Oct;8(5):477-84. https://doi.org/10.1016/0014-2964(72)90097-7

1973

• Catovsky D, Galton DAG. Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells. J Clin Pathol. 1973 Jan;26(1):60-9. 
• Spiers AS, Tattersall MH, Galton DAG. Splenectomy and leucopheresis in chronic granulocytic leukaemia. Br Med J. 1973 Jun 9;2(5866):610. 
• Catovsky D, Pettit JE, Galton DAG. Diagnostic features of leukaemic reticuloendotheliosis. Br J Haematol. 1973 Aug;25(2):278-9. 
• Catovsky D, Galetto J, Okos A, Galton DAG, Wiltshaw E, Stathopoulos G. Prolymphocytic leukaemia of B and T cell type. Lancet. 1973 Aug 4;2(7823):232-4. 

1974

• Catovsky D, Pettit JE, Galton DAG, Spiers AS, Harrison CV. Leukaemic reticuloendotheliosis (‘Hairy’ cell leukaemia): a distinct clinico-pathological entity. Br J Haematol. 1974 Jan;26(1):9-27. 
• Catovsky D, Pettit JE, Galetto J, Okos A, Galton DAG. The B-lymphocyte nature of the hairy cell of leukaemic reticuloendotheliosis. Br J Haematol. 1974 Jan;26(1):29-37. 
• Galton DAG, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ. Prolymphocytic leukaemia. Br J Haematol. 1974 May;27(1):7-23. 
• Kaur J, Catovsky D, Spiers AS, Galton DAG. Increase of T lymphocytes in the spleen in chronic granulocytic leukaemia. Lancet. 1974 May 4;1(7862):834-6. 
• Catovsky D, Goldman JM, Okos A, Frisch B, Galton DAG. T-lymphoblastic leukaemia: a distinct variant of acute leukaemia. Br Med J. 1974 Jun 22;2(5920):643-6. 
• Spiers AD, Costello C, Catovsky D, Galton DAG, Goldman JM. Chronic granulocytic leukaemia: multiple-drug chemotherapy for acute transformation. Br Med J. 1974 Jul 13;3(5923):77-80. 
• Galton DAG, Hardisty RM. Allopurinol in leukaemias and lymphomas. Lancet. 1974 Jul 20;2(7873):160-1. 
• Catovsky D, Miliani E, Okos A, Galton DAG. Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet. 1974 Sep 28;2(7883):751-2. 
• Catovsky D, Galetto J, Okos A, Miliani E, Galton DAG. Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia. J Clin Pathol. 1974 Oct;27(10):767-71. 
• Kaur J, Spiers AS, Catovsky D, Galton DAG. Increase of T lymphocytes in the spleen in Hodgkin’s disease. Lancet. 1974 Oct 5;2(7884):800-2. 

1975

• Spiers AS, Baikie AF, Galton DAG, Richards HG, Wiltshaw E, Goldman JM, Catovsky D, Spencer J, Peto R. Chronic granulocytic leukaemia: effect of elective splenectomy on the course of disease. Br Med J. 1975 Jan 25;1(5951):175-9. 
• Lowenthal RM, Grossman L, Goldman JM, Storring RA, Buskard NA, Park DS, Murphy BC, Spiers AS, Galton DAG. Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet. 1975 Feb 15;1(7903):353-8. 
• Peto R, Galton DAG. Chemoimmunotherapy of adult acute leukaemia. Lancet. 1975 Feb 22;1(7904):454. 
• Spiro S, Galton DAG, Wiltshaw E, Lohmann RC. Follicular lymphoma: A survey of 75 cases with special reference to the syndrome resembling chronic lymphocytic leukaemia. Br J Cancer Suppl. 1975 Mar;2:60-72. 
• Kaur J, Spiers AS, Galton DAG. Letter: T and B lymphocytes in spleens of patients with malignant diseases. Lancet. 1975 Mar 29;1(7909):747. 
• Galton DAG. Leon Szur: an appreciation. Br J Haematol. 1975 Apr;29(4):667-8. 
• Spiers AS, Galton DAG, Kaur J, Goldman JM. Thioguanine as primary treatment for chronic granulocytic leukaemia. Lancet. 1975 Apr 12;1(7911):829-32. 
• Geary CG, Catovsky D, Wiltshaw E, Milner GR, Scholes MC, Van Noorden S, Wadsworth LD, Muldal S, MacIver JE, Galton DAG. Chronic myelomonocytic leukaemia. Br J Haematol. 1975 Jul;30(3):289-302. 
• Kaur J, Spiers AS, Galton DAG. Splenic lymphocytes in chronic granulocytic leukaemia. Lancet. 1975 Jul 5;2(7923):40. 
• Spiers AS, Baikie AG, Galton DAG, Kaur J, Catovsky D, Goldman JM, Wiltshaw E, Lowenthal RM, Buskard NA. Splenectomy for complications of chronic granulocytic leukaemia. Lancet. 1975 Oct 4;2(7936):627-30. 
• Lowenthal RM, Buskard NA, Goldman JM, Spiers AS, Bergier N, Graubner M, Galton DAG. Intensive leukapheresis as initial therapy for chronic granulocytic leukemia. Blood. 1975 Dec;46(6):835-44. 
• Spiers AS, Roberts PD, Marsh GW, Parekh SJ, Franklin AJ, Galton DAG, Szur ZL, Paul EA, Husband P, Wiltshaw E. Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen). Br Med J. 1975 Dec 13;4(5997):614-7. 

1976

• Buskard NA, Catovsky D, Okos A, Goldman JM, Galton DAG. Prolymphocytic leukaemia: cell studies and treatment by leucapheresis. Hamatol Bluttransfus. 1976;18:237-50.
• Goldman JM, Th’ng KH, Catovsky D, Galton DAG. Production of colony stimulating factor by leukemic leucocytes. Blood. 1976 Mar;47(3):381-8. 
• Catovsky D, Cherchi M, Okos A, Hegde U, Galton DAG. Mouse red-cell rosettes in B-lymphoproliferative disorders. Br J Haematol. 1976 Jun;33(2):173-7. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451-8. 
• Beard MD, Durrant J, Catovsky D, Wiltshaw E, Amess JL, Brearley RL, Kirk B, Wrigley PF, Janossy G, Greaves MF, Galton DAG. Blast crisis of chronic myeloid leukaemia (CML). I. Presentation simulating acute lymphoid leukaemia (ALL). Br J Haematol. 1976 Oct;34(2):167-78. 
• Kramers MT, Catovsky D, Foa R, Cherchi M, Galton DAG. 5′ nucleotidase activity in leukaemic lymphocytes. Biomedicine. 1976 Dec 30;25(10):363-5.

1977

• Catovsky D, Galton DAG. Cell markers and the classification of acute leukaemia. Haematol Blood Transfus. 1977;20:25-31. 
• Kramers MTC, Catovsky D, Cherchi M, Galton DAG. 5′nucleotidase in cord blood lymphocytes. Leuk Res. 1977;1(4):279-281. 
• Murray KH, Paolino F, Goldman JM, Galton DAG, Grindle CF. Ocular involvement in leukaemia. Report of three cases. Lancet. 1977 Apr 16;1(8016):829-31. 
• Spiers AS, Goldman JM, Catovsky D, Costello C, Buskard NA, Galton DAG. Multiple-drug chemotherapy for acute leukemia The TRAMPCOL regimen: results in 86 patients. Cancer. 1977 Jul;40(1):20-9. 
• Buskard NA, Galton DAG, Goldman JM, Kohner EM, Grindle CF, Newman DL, Twinn KW, Lowenthal RM. Plasma exchange in the long-term management of Waldenström’s macroglobulinemia. Can Med Assoc J. 1977 Jul 23;117(2):135-7. 
• Catovsky D, Sperandio P, O’Brien M, Cherchi M, Galton DAG. Phagocytic potential of leukaemic B-lymphocytes. Scand J Haematol. 1977 Aug;19(2):211-6. 
• Spiers AS, Goldman JM, Catovsky D, Costello C, Galton DAG, Pitcher CS. Prolonged remission maintenance in acute myeloid leukaemia. Br Med J. 1977 Aug 27;2(6086):544-7. 
• Galton DAG, Kay HE, Reizenstein P, Penchansky M, Vogler WR, Whittaker JA. Infection and second-remission rates in patients having immunotherapy for acute myeloid leukaemia. Lancet. 1977 Nov 5;2(8045):973. 
• Gralnick HR, Galton DAG, Catovsky D, Bennett JM, Sultan C. Classification of acute leukemia. Ann Intern Med. 1977 Dec 1;87(6):740-753. 
• Stott H, Fox W, Girling DJ, Stephens RJ, Galton DAG. Acute leukaemia after busulphan. Br Med J. 1977 Dec 10;2(6101):1513-7. 

1978

• Catovsky D, Cherchi M, Galton DAG, Hoffbrand AV, Ganeshaguru K. Cell differentiation in B and T‑lympho proliferative disorders. In Clarkson B, Marks PA, Till JE, Eds. Differentiation of Normal and Neoplastic Hematopoietic Cells. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1978: 811‑822.
• Dacie JV, Galton DAG, Gordon-Smith EC, Harrison CV. Non-tropical ‘idiopathic splenomegaly’: a follow-up study of ten patients described in 1969. Br J Haematol. 1978 Feb;38(2):185-93. 
• Catovsky D, Goldman JM, Galton DAG. Survival after relapse in acute myeloid leukaemia. Lancet. 1978 Feb 4;1(8058):266-7. https://doi.org/10.1016/s0140-6736(78)90504-4
• Goldman JM, Catovsky D, Galton DAG. Reversal of blast-cell crisis in C.G.L. by transfusion of stored autologous buffy-coat cells. Lancet. 1978 Feb 25;1(8061):437-8. 
• Galton DAG, Catovsky D, Wiltshaw E. Clinical spectrum of lymphoproliferative diseases. Cancer. 1978 Aug;42(2 Suppl):901-10. 
• Enno A, Catovsky D, Darrell J, Goldman JM, Hows J, Galton DAG. Co-trimoxazole for prevention of infection in acute leukaemia. Lancet. 1978 Aug 19;2(8086):395-7. 

1979

• Galton DAG. Can remission duration be prolonged in acute myeloid leukaemia? Recent Results Cancer Res. 1979;69:55-62. 
• Enno A, Catovsky D, O’Brien M, Cherchi M, Kumaran TO, Galton DAG. ‘Prolymphocytoid’ transformation of chronic lymphocytic leukaemia. Br J Haematol. 1979 Jan;41(1):9-18. 
• Vicariot M, Goldman JM, Catovsky D, Galton DAG. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan. Eur J Cancer. 1979 Apr;15(4):559-63. 
• Islam A, Catovsky D, Goldman JM, Galton DAG. Value of long-core biopsy in detection of discrete bone-marrow lesions. Lancet. 1979 Apr 21;1(8121):878. https://doi.org/10.1016/s0140-6736(79)91293-5
• Buskard NA, Kaur J, Goldman JM, Spiers AS, Galton DAG. Engraftment with chronic granulocytic leukemia cells in acute myeloid leukemia. Transfusion. 1979 May-Jun;19(3):317-20. https://doi.org/10.1046/j.1537-2995.1979.19379204214.x
• Goldman JM, Catovsky D, Hows J, Spiers AS, Galton DAG. Cryopreserved peripheral blood cells functioning as autografts in patients with chronic granulocytic leukaemia in transformation. Br Med J. 1979 May 19;1(6174):1310-3. 
• Foa R, Catovsky D, Brozovic M, Marsh G, Ooyirilangkumaran T, Cherchi M, Galton DAG. Hodgkin’s disease. Br Med J. 1979 Sep 8;2(6190):587-9. 

1980

• Suri R, Goldman JM, Catovsky D, Johnson SA, Wiltshaw E, Galton DAG. Priapism complicating chronic granulocytic leukemia. Am J Hematol. 1980;9(3):295-9. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. A variant form of hypergranular promyelocytic leukaemia (M3). Br J Haematol. 1980 Jan;44(1):169-70. 
• Lampert I, Catovsky D, Marsh GW, Child JA, Galton DAG. The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia. Histopathology. 1980 Jan;4(1):3-19. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med. 1980 Feb;92(2 Pt 1):261. 
• Costello C, Catovsky D, O’Brien M, Galton DAG. Prolymphocytic leukaemia: an ultrastructural study of 22 cases. Br J Haematol. 1980 Mar;44(3):389-94. 
• Manoharan A, Catovsky D, Goldman JM, Lauria F, Lampert IA, Galton DAG. Significance of splenomegaly in childhood acute lymphoblastic leukaemia in remission. Lancet. 1980 Mar 1;1(8166):449-52. 
• Gattiker HH, Wiltshaw E, Galton DAG. Haematological reconstitution after autografting for chronic granulocytic leukaemia in transformation: the influence of previous splenectomy. Br J Haematol. 1980 Jun;45(2):223-31. 
• Catovsky D, Bernasconi C, Verdonck PJ, Postma A, Hows J, van der Does-van den Berg A, Rees JK, Castelli G, Morra E, Galton DAG. The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol. 1980 Aug;45(4):523-34. 
• Islam A, Catovsky D, Galton DAG. Histological study of bone marrow regeneration following chemotherapy for acute myeloid leukaemia and chronic granulocytic leukaemia in blast transformation. Br J Haematol. 1980 Aug;45(4):535-40. 
• Oscier DG, Goldman JM, Galton DAG, Kumaran TO. Infusion of autologous buffy coat cells for CGL in transformation. Lancet. 1980 Aug 9;2(8189):308-9. 
• Foa R, Catovsky D, Lauria F, Galton DAG. Reduced T-colony forming capacity by T-lymphocytes from B-chronic lymphocyte leukaemia. Br J Haematol. 1980 Dec;46(4):623-5. 

1981

• Goldman JM, Johnson SA, Starke ID, Wareham NJ, Catovsky D, Galton DAG. Autografting for patients with chronic granulocytic leukaemia in transformation. In Touraine JL, Gluckman E, Griscelli C, Eds. Bone Marrow Transplantation in Europe II. Proceedings of the Fifth European Symposium on Bone Marrow Transplantation, Courchevel, Savoie, France, March 16-18, 1981. Amsterdam, Netherlands: Excerpta Medica; 1981:58‑62.
• Manoharan A, Catovsky D, Lampert IA, Al-Mashadhani, Gordon-Smith EC, Galton DAG. Histiocytic medullary reticulosis complicating chronic lymphocytic leukaemia: malignant or reactive? Scand J Haematol. 1981 Jan;26(1):5-13. 
• Foa R, Catovsky D, Lauria F, Zafar MN, Galton DAG. T-lymphocytes in B-cell chronic lymphocytic leukaemia. Haematologica. 1981 Feb;66(1):105-16.
• Goldman JM, Johnson SA, Catovsky D, Agnarsdottir G, Goolden AW, Galton DAG. Identical twin marrow transplantation for patients with leukemia and lymphoma. Transplantation. 1981 Feb;31(2):140-1. 
• Goldman JM, Catovsky D, Goolden AW, Johnson SA, Galton DAG. Buffy coat autografts for patients with chronic granulocytic leukaemia in transformation. Blut. 1981 Mar;42(3):149-55. 
• Catovsky D, Lauria F, Matutes E, Foa R, Mantovani V, Tura S, Galton DAG. Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Br J Haematol. 1981 Apr;47(4):539-44. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol. 1981 Apr;47(4):553-61. 
• Manoharan A, Catovsky D, Clein P, Traub NE, Costello C, O’Brien M, Boralessa H, Galton DAG. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases. Br J Haematol. 1981 May;48(1):111-6. 
• Islam A, Catovsky D, Goldman JM, Galton DAG. Histological study of the bone marrow in chronic granulocytic leukaemia in blast transformation. I. Serial observations before and after autografting. Histopathology. 1981 Jul;5(4):339-51. 
• Bain BJ, Catovsky D, O’Brien M, Prentice HG, Lawlor E, Kumaran TO, McCann SR, Matutes E, Galton DAG. Megakaryoblastic leukemia presenting as acute myelofibrosis — a study of four cases with the platelet-peroxidase reaction. Blood. 1981 Aug;58(2):206-13. 
• Oscier DG, Catovsky D, Errington RD, Goolden AW, Roberts PD, Galton DAG. Splenic irradiation in B-prolymphocytic leukaemia. Br J Haematol. 1981 Aug;48(4):577-84. 
• Islam A, Catovsky D, Goldman JM, Galton DAG. Histological study of the bone marrow in chronic granulocytic leukaemia in blast transformation. II. Bone marrow fibre content before and after autografting. Histopathology. 1981 Sep;5(5):491-8. 
• Goldman JM, Johnson SA, Catovsky D, Wareham NJ, Galton DAG. Autografting for chronic granulocytic leukemia. N Engl J Med. 1981 Sep 17;305(12):700. 
• Catovsky D, de Salvo Cardullo L, O’Brien M, Morilla R, Costello C, Galton DAG, Ganeshaguru K, Hoffbrand V. Cytochemical markers of differentiation in acute leukemia. Cancer Res. 1981 Nov;41(11 Pt 2):4824-32. 

1982

• Foa R, Lauria F, Catovsky D, Galton DAG. Reduced T-colony forming capacity in B-chronic lymphocytic leukaemia.–II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia. Leuk Res. 1982;6(3):329-33. 
• Starke ID, Donnelly P, Catovsky D, Darrell J, Johnson SA, Goldman JM, Galton DAG. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. Lancet. 1982 Jan 2;1(8262):5-6. 
• Catovsky D, Greaves MF, Rose M, Galton DAG, Goolden AW, McCluskey DR, White JM, Lampert I, Bourikas G, Ireland R, Brownell AI, Bridges JM, Blattner WA, Gallo RC. Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet. 1982 Mar 20;1(8273):639-43. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982 Jun;51(2):189-99. 
• Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DAG, Sarin PS, Crawford MH, Catovsky D, Greaves M, Gallo RC. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer. 1982 Sep 15;30(3):257-64. 
• Goldman JM, Baughan AS, McCarthy DM, Worsley AM, Hows JM, Gordon-Smith EC, Catovsky D, Batchelor JR, Goolden AW, Galton DAG. Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia. Lancet. 1982 Sep 18;2(8299):623-5. 
• Galton DAG, MacLennan IC. Clinical patterns in B lymphoid malignancy. Clin Haematol. 1982 Oct;11(3):561-87.
• Starke ID, Thein SL, Goldman JM, Galton DAG. Graft-versus-host disease after treatment for chronic granulocytic leukaemia in transformation. Br J Haematol. 1982 Nov;52(3):383-7. 
• Buckman R, Cuzick J, Galton DAG. Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults. Br J Haematol. 1982 Dec;52(4):589-99. 

1983

• Galton DAG, Goldman JM, Catovsky D. The treatment of chronic granulocytic leukaemia. In Hollán SR, Ed. Recent advances in haematology, immunology, and blood transfusion: proceedings of the plenary sessions of the joint meeting of the 19th congress of the International Society of Haematology and the 17th congress of the International Society of Blood Transfusion, Budapest, August 1982. Chichester, UK: Wiley; 1983:197‑209.
• Mehta AB, Baughan AS, Catovsky D, Goldman JM, Johnson SA, Galton DAG. Reversal of marrow fibrosis in acute megakaryoblastic leukaemia after remission-induction and consolidation chemotherapy followed by bone marrow transplantation. Br J Haematol. 1983 Mar;53(3):445-9. 
• Goolden AW, Goldman JM, Kam KC, Dunn PA, Baughan AS, McCarthy DM, Worsley AM, Gordon-Smith EC, Samson D, Catovsky D, Galton DAG. Fractionation of whole body irradiation before bone marrow transplantation for patients with leukaemia. Br J Radiol. 1983 Apr;56(664):245-50. 
• Cohen J, Donnelly JP, Worsley AM, Catovsky D, Goldman JM, Galton DAG. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet. 1983 Dec 24-31;2(8365-66):1452-4. 

1984

• Galton DAG. The myelodysplastic syndromes. Clin Lab Haematol. 1984;6(2):99-112. 
• Goldman JM, Wyatt SE, Baughan ASJ, Cranfield T, McCarthy DM, Worsley AM, Yin J, Reid CD, Catovsky D, Gordon‑Smith EC, Galton DAG. Allogeneic bone marrow transplantation (BMT) for chronic granulocytic leukaemia (CGL). Exp Hematol. 1984;12(Suppl 15):34‑35.
• Islam A, Catovsky D, Goldman JM, Galton DAG. Studies on cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrows. Bibl Haematol. 1984;(50):17-30. 
• Baughan AS, Worsley AM, McCarthy DM, Hows JM, Catovsky D, Gordon-Smith EC, Galton DAG, Goldman JM. Haematological reconstitution and severity of graft-versus-host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy. Br J Haematol. 1984 Mar;56(3):445-54. 
• Donnelly JP, Starke ID, Galton DAG, Catovsky D, Goldman JM, Darrell JH. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia. J Hosp Infect. 1984 Mar;5(1):83-91. 
• Islam A, Catovsky D, Goldman JM, Galton DAG. Histomorphological study of cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrow. Histopathology. 1984 Mar;8(2):293-313. https://doi.org/10.1111/j.1365-2559.1984.tb02343.x
• Rowe IF, Worsley AM, Donnelly P, Catovsky D, Goldman JM, Galton DAG, Pepys MB. Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia. J Clin Pathol. 1984 Mar;37(3):263-6. https://doi.org/10.1136/jcp.37.3.263
• Starke ID, de Beer FC, Donnelly JP, Catovsky D, Goldman JM, Galton DAG, Pepys MB. Serum C-reactive protein levels in the management of infection in acute leukaemia. Eur J Cancer Clin Oncol. 1984 Mar;20(3):319-25. 
• Worsley AM, Galton DAG. Acute myeloid leukaemia: is ‘consolidation’ therapy necessary? Br J Haematol. 1984 Mar;56(3):361-4. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Myelodysplastic syndromes: is another classification necessary? Br J Haematol. 1984 Mar;56(3):515-7. 
• Marcus RE, Catovsky D, Goldman JM, Worsley AM, Galton DAG. Maintenance and consolidation therapy in AML. Lancet. 1984 Mar 24;1(8378):686-7. 
• Worsley AM, Catovsky D, Goldman JM, Galton DAG. New combination chemotherapy for relapsed acute myeloid leukaemia. Lancet. 1984 Jun 2;1(8388):1232. https://doi.org/10.1016/s0140-6736(84)91709-4
• Goldman JM, Gordon-Smith EC, Catovsky D, Galton DAG, Reid C. Timing of transplant for CML patients. Blood. 1984 Oct;64(4):945-6. https://doi.org/10.1182/blood.V64.4.945.945
• Dowding C, Th’ng KH, Goldman JM, Galton DAG. Increased T-lymphocyte numbers in chronic granulocytic leukemia before treatment. Exp Hematol. 1984 Nov;12(10):811-15.
• Islam A, Catovsky D, Goldman JM, Galton DAG. Bone marrow fibre content in acute myeloid leukaemia before and after treatment. J Clin Pathol. 1984 Nov;37(11):1259-63. 
• Haines ME, Goldman JM, Worsley AM, McCarthy DM, Wyatt SE, Dowding C, Kearney L, Th’ng KH, Wareham NJ, Pollock A, Galvin MC, Samson D, Geary CG, Catovsky D, Galton DAG. Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients. Br J Haematol. 1984 Dec;58(4):711-21. https://doi.org/10.1111/j.1365-2141.1984.tb06118.x
• Wyatt SE, Nunn P, Hows JM, Yin J, Hayes MC, Catovsky D, Gordon-Smith EC, Hughes JM, Goldman JM, Galton DAG. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax. 1984 Dec;39(12):887-94. 

1985

• Marcus RE, Catovsky D, Goldman JM, Galton DAG, Newland AC, Slocombe G, Hegde U. Mitozantrone and high-dose cytarabine in adult acute myeloid leukaemia. Lancet. 1985 Jun 15;1(8442):1384. 
• Hansen OP, Galton DAG. Classification and prognostic variables in myelomatosis. Scand J Haematol. 1985 Jul;35(1):10-9. https://doi.org/10.1111/j.1600-0609.1985.tb00792.x
• Dharmasena F, Chu AC, Goldman JM, Galton DAG. Mitozantrone-induced asteatosis. Lancet. 1985 Jul 13;2(8446):101. https://doi.org/10.1016/s0140-6736(85)90204-1
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med. 1985 Sep;103(3):460-2. 
• Islam A, Catovsky D, Goldman JM, Galton DAG. Bone marrow biopsy changes in acute myeloid leukaemia. I: Observations before chemotherapy. Histopathology. 1985 Sep;9(9):939-57. 
• Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985 Oct;103(4):620-5. https://doi.org/10.7326/0003-4819-103-4-620
• Donnelly JP, Marcus RE, Goldman JM, Cohen J, Worsley AM, Catovsky D, Darrell JH, Want SV, Galton DAG. Ceftazidime as first-line therapy for fever in acute leukaemia. J Infect. 1985 Nov;11(3):205-15. https://doi.org/10.1016/s0163-4453(85)93063-4
• Parreira L, Matutes E, Marcus RE, Brito-Babapulle V, Parreira A, Goldman JM, Galton DAG, Catovsky D. Atypical promyelocytic leukemia (M3) with immature primary granules and t(15;17). Cancer Genet Cytogenet. 1985 Dec;18(4):315-24. 
• Sokal JE, Baccarani M, Tura S, Fiacchini M, Cervantes F, Rozman C, Gomez GA, Galton DAG, Canellos GP, Braun TJ, Clarkson BD, Carbonell F, Heimpel H, Extra JM, Fiere D, Nissen NI, Robertson JE, Cox EB. Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood. 1985 Dec;66(6):1352-7. 

1986

• Dharmasena F, Littlewood T, Gordon-Smith EC, Catovsky D, Galton DAG. Adult acute lymphoblastic leukaemia presenting with bone marrow aplasia. Clin Lab Haematol. 1986;8(4):361-4. 
• Galton DAG. The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Scand J Haematol Suppl. 1986;45:11-20.
• Haines ME, Catovsky D, Galton DAG. Remission of the nephrotic syndrome associated with chronic lymphocytic leukaemia. Clin Lab Haematol. 1986;8(4):366-8. 
• Marcus RE, Catovsky D, Johnson SA, Gregory WM, Talavera JG, Goldman JM, Galton DAG. Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period. Br J Cancer. 1986 Feb;53(2):175-80. https://doi.org/10.1038/bjc.1986.32
• Dharmasena F, Galton DAG. Circulating blasts in acute myeloid leukaemia in remission. Br J Haematol. 1986 May;63(1):211-3. https://doi.org/10.1111/j.1365-2141.1986.tb07514.x
• Melo JV, Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986 Jun;63(2):377-87. https://doi.org/10.1111/j.1365-2141.1986.tb05563.x
• Melo JV, Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of ‘prolymphocytoid’ transformation. Br J Haematol. 1986 Sep;64(1):77-86. 
• Spiers AS, Drysdale HC, Galton DAG, Richards HG. Four case pairs with chronic granulocytic leukemia. JAMA. 1986 Sep 5;256(9):1137. 
• Ganesan TS, Rassool F, Guo AP, Th’ng KH, Dowding C, Hibbin JA, Young BD, White H, Kumaran TO, Galton DAG, Goldman JM. Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia. Blood. 1986 Oct;68(4):957-60.
• Melo JV, Wardle J, Chetty M, England J, Lewis SM, Galton DAG, Catovsky D. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements. Br J Haematol. 1986 Nov;64(3):469-78. 
• Dharmasena F, Englert H, Catovsky D, Galton DAG, Drysdale HC. Incomplete Reiter’s syndrome following chemotherapy of acute myeloid leukaemia. Postgrad Med J. 1986 Nov;62(733):1045-6. 
• Mufti GJ, Galton DAG. Myelodysplastic syndromes: natural history and features of prognostic importance. Clin Haematol. 1986 Nov;15(4):953-71.
• Dharmasena F, Wickham N, McHugh PJ, Catovsky D, Galton DAG. 1987
  • Ganesan TS, Rassool F, Guo AP, Young BD, Galton DAG, Goldman JM. Rearrangement of the bcr gene in Philadelphia-chromosome-negative chronic myeloid leukemia. Haematol Blood Transfus. 1987;31:153-9. 
  • Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RF, Hann IM, Goldman JM, Hoffbrand AV, Galton DAG. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985. Haematol Blood Transfus. 1987;30:346-51. 
  • Melo JV, Catovsky D, Galton DAG. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal. Blood Cells. 1987;12(2):339-53.
  • Melo JV, Catovsky D, Gregory WM, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. Br J Haematol. 1987 Jan;65(1):23-9. https://doi.org/10.1111/j.1365-2141.1987.tb06130.x
  • Brito-Babapulle F, Catovsky D, Slocombe G, Newland AC, Marcus RE, Goldman JM, Galton DAG. Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia. Cancer Treat Rep. 1987 Feb;71(2):161-3.
  • Cuzick J, Erskine S, Edelman D, Galton DAG. A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council’s working party on leukaemia in adults. Br J Cancer. 1987 May;55(5):523-9. 
  • Brito-Babapulle F, Catovsky D, Newland AC, Goldman JM, Galton DAG. Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone. Semin Oncol. 1987 Jun;14(2 Suppl 1):51-2.
  • Yamaguchi K, Matutes E, Catovsky D, Galton DAG, Nakada K, Takatsuki K. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. Lancet. 1987 Jul 11;2(8550):94-5. 
  • Brito-Babapulle F, Catovsky D, Galton DAG. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol. 1987 Aug;66(4):445-50. 
  • Galton DAG, Brito-Babapulle F. The management of myelomatosis. Eur J Haematol. 1987 Nov;39(5):385-98. 
  • Shepherd PC, Ganesan TS, Galton DAG. Haematological classification of the chronic myeloid leukaemias. Baillieres Clin Haematol. 1987 Dec;1(4):887-906. 

  1988

  • Galton DAG. B-chronic lymphocytic leukemia: some diagnostic and clinical aspects. In Polliack A, Catovsky D, Eds. Chronic Lymphocytic Leukemia. Chur, Switzerland: Harwood Academic Publishers; 1988: 33-45.
  • Wiedemann LM, Karhi KK, Shivji MK, Rayter SI, Pegram SM, Dowden G, Bevan D, Will A, Galton DAG, Chan LC. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood. 1988 Feb;71(2):349-55. 
  • Brito-Babapulle F, Catovsky D, Galton DAG. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation. Br J Haematol. 1988 Apr;68(4):411-5. 
  • Melo JV, Robinson DS, De Oliveira MP, Thompson IW, Lampert IA, Ng JP, Galton DAG, Catovsky D. Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. J Clin Pathol. 1988 Sep;41(9):951-9. 

  1989

  • Galton DAG. Terminal transformation in B-cell chronic lymphocytic leukaemia. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:156-7.
  • Bowcock SJ, Galton DAG, Goldman JM. Marrow aplasia developing 3 years after treatment with busulphan for chronic myeloid leukaemia. Eur J Haematol. 1989 May;42(5):496-7. https://doi.org/10.1111/j.1600-0609.1989.tb01477.x
  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol. 1989 Jun;42(6):567-84. 
  • Brito-Babapulle F, Bowcock SJ, Marcus RE, Apperley J, Th’ng KH, Dowding C, Rassool F, Guo AP, Catovsky D, Galton DAG, McCarthy D, Goldman JM. Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. Br J Haematol. 1989 Sep;73(1):76-81. 
  • Galton DAG. The myelodysplastic syndrome. BMJ. 1989 Sep 2;299(6699):582. 
  • Galton DAG, Spiers AS. Development of chronic granulocytic leukaemia in the absence of a spleen. Lancet. 1989 Sep 30;2(8666):805. 
  • Binet JL, Catovsky D, Chastang C, Dighiero G, Fooks J, Galton DAG, Gates A, Hamblin TJ, Han T, Hansen MM, Keating MJ, Montserrat E, Pangalis GA, Polliack A, Rai KR, Richards S, International Workshop on CLL. Prognostic features of early chronic lymphocytic leukaemia. Lancet. 1989 Oct 21;334(8669):968-969. 

  1990

  • Morgan GJ, Wiedemann LM, Chan LC, Price CM, Kanfer EJ, Galton DAG. A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML. Blood. 1990 Jan 1;75(1):317-8. 
  • Dokal IS, Cox TM, Galton DAG. Vitamin B-12 and folate deficiency presenting as leukaemia. BMJ. 1990 May 12;300(6734):1263-4. 
  • Dokal IS, Cox TM, Galton DAG. Vitamin B-12 and folate deficiency presenting as leukaemia: authors; reply. BMJ. 1990 Jul 7;301(6742):42. 

  1991

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol. 1991 Jul;78(3):325-9. 

  1992

  • Galton DAG. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia. Leuk Lymphoma. 1992 Aug;7(5-6):343-50. 

  1994

  • Melo JV, Myint H, Galton DAG, Goldman JM. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? Leukemia. 1994 Jan;8(1):208-11.
  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C, Cox C. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol. 1994 Aug;87(4):746-54. 

  2000

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Willman CL. Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17). Leukemia. 2000 Jul;14(7):1197-200.